Interv Akut Kardiol. 2012;11(2):89-90

Léčba statiny u pacientů s akutním koronárním syndromem

Za kolektiv autorů:, Jan Pi»ha1, 2, Tomáą ©tulc2, 3, Tomáą Janota3, 4, Vasiµ Hricák5, 6
1 Laboratoř pro výzkum aterosklerózy, IKEM, Praha
2 Česká společnost pro aterosklerózu
3 III. interní klinika 1. LF UK a VFN, Praha
4 Pracovní skupina akutní kardiologie České kardiologické společnosti
5 Národný ústav srdcových a cievnych chorôb, Bratislava
6 Pracovná skupina akútnej kardiológie Slovenskej kardiologickej spoločnosti

Společné stanovisko České společnosti pro aterosklerózu, Pracovní skupiny akutní kardiologie České kardiologické společnosti a Pracovnej skupiny akútnej kardiológie Slovenskej kardiologickej spoločnosti

Published: April 23, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
kolektiv autorů: Z, Pi»ha J, ©tulc T, Janota T, Hricák V. Léčba statiny u pacientů s akutním koronárním syndromem. Interv Akut Kardiol. 2012;11(2):89-90.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. ESC/EAS Guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology and the European Atherosclerosis Society. European Heart Journal 2011; 32: 1769-1818.
    2. De Lemos JA, Blazing MA, Wiviott SD, et al. Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes: phase Z of the A to Z Trial. JAMA, 292 2004: 1307-1316. Go to original source... Go to PubMed...
    3. Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA, 2001; 285: 1711-1718. Go to original source... Go to PubMed...
    4. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495-1504. Go to original source... Go to PubMed...
    5. Briel M, Vale N, Schwartz GG, et al. Updated evidence on early statin therapy for acute coronary syndromes: Meta-analysis of 18 randomized trials involving over 14,000 patients Int J Cardiol. 2011 Feb 3. [Epub ahead of print], doi: 10.1016/j.ijcard.2011; 01: 033. Go to original source...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.